{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:31:22Z","timestamp":1761708682063},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.5414\/cp201557","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T10:56:16Z","timestamp":1306493776000},"page":"467-468","source":"Crossref","is-referenced-by-count":6,"title":["Silymarin as a potential novel addition to the limited anti-vitiligo weaponry: an untested hypothesis"],"prefix":"10.5414","volume":"49","author":[{"given":"A","family":"Feily","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Namazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T10:45:19Z","timestamp":1378464319000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=8712&doi=10.5414\/CP201557&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":0,"journal-issue":{"issue":"07","published-print":{"date-parts":[[2011]]}},"alternative-id":["201557"],"URL":"https:\/\/doi.org\/10.5414\/cp201557","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}